Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
NXNextCure, Inc. logo

NextCure, Inc. (NXTC)

NASDAQ Global Select · Currency in USD
$5.23 ▲ +0.33 (+6.63%)
At close: Oct 26, 4:00 PM ET. Market closed.

Summary

Previous Close
$4.90
Open
$4.91
Day's Range
$4.78 – $5.48
52 Week Range
$1.55 – $15.74
Volume
25,195
Avg. Volume
2,133,541
Market Cap
$23.92M
Beta (5Y Monthly)
1.35
PE Ratio (TTM)
--
EPS (TTM)
-$8.05
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$20.00

Profile: NextCure, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
40
CEO
Michael S. Richman

NextCure, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative immunotherapies. Its core mission is to combat cancer and various other immune-related conditions by reactivating normal immune system function. The company's leading investigational compound, NC318, is currently in Phase II clinical trials, focusing on the treatment of advanced or metastatic solid tumors.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate -$0.90
DateEst.Actual
Aug 6, 2026-$1.95-$2.80Miss
May 7, 2026-$1.81-$1.87Miss
Mar 5, 2026-$2.26-$0.81Beat
Nov 5, 2025-$4.06-$3.22Beat
Aug 7, 2025-$4.62-$11.29Miss
May 1, 2025-$4.80-$4.68Beat

Analyst view

Consensus price target
$20.00 ▲ +282.8%
Range $20.00 – $20.00
Rating: Buy
Buy 85% · Hold 8% · Sell 8%

Get free alerts on NXTC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.